THE CHRISTIE CHARITY

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  +17.2%

  £68,620,000 → £80,446,000

• Net assets

  -0.8%

  £56,603,000 → £56,137,000

• Employees

  —

  Not reported

• Wages

  +12.5%

  £1,365,000 → £1,536,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Buzzacott Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group and charitable parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

1. THE CHRISTIE CHARITY · parent
   1. The Christie Trading Company Limited 1% · England and Wales · sales of items of a fundraising and promotional nature
   2. Northern Pathology Developments Limited 1% · England and Wales · construction activities of a new pathology development

Significant events

• “The opening of the state-of-the-art Paterson building promotes the seamless integration of research with clinical care.”
• “Our complementary therapy service has expanded and is now available not only at our Withington site, but at both Macclesfield and Oldham ensuring equitable support for all patients.”
• “Installation of a state-of-the-art PET-CT scanner at The Christie would primarily be a resource for routine clinical work and also for dedicated research capacity in the context of clinical trials and for PET-CT as a research tool in its own right.”
• “The construction of the new pathology facility is the Charity's first social investment opportunity and will be managed by Northern Pathology Developments Limited, which was incorporated on 9 January 2025 and established as a subsidiary of The Christie Charity.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.